Ticagrelor Dr. Reddy's 90 mg film-coated tablets

Ticagrelor Dr. Reddy's is a generic cardiovascular medication used to prevent blood clots and reduce the risk of heart attacks and strokes. The product is a generic version of the brand-name drug Brilinta.

The brand originated with Dr. Reddy's Laboratories, an Indian multinational pharmaceutical company founded in 1984 by Kallam Anji Reddy in Hyderabad, India. The company has since grown into a global leader in generic medicines and active pharmaceutical ingredients (APIs).

Manufacturing of the active substance (Ticagrelor) and the finished dosage forms typically takes place at Dr. Reddy's state-of-the-art facilities in India, such as those in Andhra Pradesh, which are certified for export to the European Union and other global markets. The brand is managed in Italy through its local subsidiary, Dr. Reddy's S.r.l., following the company's strategic expansion into the Italian market via the acquisition of Jet Generici Srl.